Study Stopped
The study was stopped due to lack of inclusions
Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.
SCEI
2 other identifiers
observational
150
2 countries
2
Brief Summary
The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 29, 2020
CompletedStudy Start
First participant enrolled
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2021
CompletedApril 27, 2023
April 1, 2023
11 months
July 27, 2020
April 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Results of the Generalized Anxiety Disorder (GAD-7)
test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry. Scored between 0-21: Cut offs: * 0-4 = None * 5-9 = Mild anxiety * 10-14 = Moderate anxiety * 15-21 = Severe anxiety
5 Minutes
Secondary Outcomes (4)
Results of the Mental Health questionnaire
5 minutes
Results of the Patient Health Questionnaire (PHQ-9)
5 minutes
Results of the Post Traumatic Stress Disorder (PTSD-8)
5 minutes
Results of the Experiences in Close Relationship Scale questionnaire (ECR-S)
5 minutes
Study Arms (1)
Volunteers
volunteers over 18 years of age
Interventions
test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry.
questionnaire on the living conditions, socio-professional contexts and environmental conditions of the participants
status of the patient with regard to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus)
know the experience of containment and isolation during the pandemic
Assessing the trauma of subjects during the pandemic
Measuring social ties and attachment of subjects
Eligibility Criteria
Health Volunteers
You may qualify if:
- Adult volunteer who agreed to answer the questionnaires
- Age ≥ 18 years old
- Adult affiliated or having a duty to a social security scheme
You may not qualify if:
- Children under 18 years old
- Inability to understand information letter, consent, or to use online questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier Universitaire de Saint-Etienne
Saint-Etienne, 42270, France
Centre de Recherche et d'Innovation Clinique
Glasgow, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claude LAMBERT, MD PhD HDR
CHU SAINT-ETIENNE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2020
First Posted
July 29, 2020
Study Start
October 22, 2020
Primary Completion
September 29, 2021
Study Completion
September 29, 2021
Last Updated
April 27, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share